share_log

Leap Therapeutics Q1 Net Loss $10.4M vs Loss $9.1M In Same Qtr. Last Year, Sales $400.00K Up From $375.00K YoY

Benzinga Real-time News ·  May 13, 2022 07:23

Leap Therapeutics (NASDAQ:LPTX) reported $400.00 thousand in sales this quarter. This is a 6.67 percent increase over sales of $375.00 thousand the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment